Aggressive NK-cell Leukemia

specific

A rare, highly aggressive, Epstein-Barr virus-associated leukemia, also known as aggressive NK-cell leukemia/lymphoma; it may represent the leukemic counterpart of nasal type extranodal NK/T-cell lymphomas. It affects primarily teenagers and young adults. It is characterized by the systemic proliferation of NK cells in the peripheral blood, bone marrow, liver, and spleen.

20

Centers

11

Active Trials

Cancer Funding

Top Centers for Aggressive NK-cell Leukemia(20)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
NCI Comprehensive
Active Research Program
62.6
2
NCI Comprehensive
Active Research Program
62.6
3
NCI Comprehensive
Active Research Program
62.6
4
NCI Comprehensive
Active Research Program
62.6
5
NCI Comprehensive
Active Research Program
62.6
6
NCI Clinical
Active Research Program
62.6
7
NCI Clinical
Active Research Program
62.6
8
Active Research Program
62.6
9
Active Research Program
62.6
10
Active Research Program
62.6
11
Active Research Program
62.6
12
NCI Comprehensive
40.1
1340.1
1440.1
1540.1
16
NCI Comprehensive
40.1
17
NCI Comprehensive
40.1
1840.1
1940.1
2040.1

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →